VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,455 | +23.5% | 99,879 | +2.0% | 0.00% | – |
| Q4 2022 | $10,083 | -28.0% | 97,890 | +5.9% | 0.00% | – |
| Q3 2022 | $14,000 | -82.5% | 92,451 | +1.4% | 0.00% | -100.0% |
| Q2 2022 | $80,000 | -32.8% | 91,146 | -5.4% | 0.00% | 0.0% |
| Q1 2022 | $119,000 | -40.8% | 96,333 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $201,000 | -30.9% | 103,114 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $291,000 | -13.9% | 106,198 | -0.9% | 0.00% | +100.0% |
| Q2 2021 | $338,000 | – | 107,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|